qSOFA score may predict prognosis in ICU patients with sepsis across socioeconomic levels: Study

Published On 2024-04-24 16:00 GMT   |   Update On 2024-04-24 16:01 GMT
Advertisement

Recent research paper investigates the association between Sequential Organ Failure Assessment (qSOFA) and 28-day mortality in intensive care unit (ICU) patients admitted for sepsis, focusing on different income settings. The study included 4980 patients from 343 ICUs and 22 countries, analyzing the association of qSOFA with early (3-day), medium (28-day), and late (90-day) mortality in low, lower middle, upper middle, and high-income countries/regions. The study found that higher qSOFA was associated with increasing 28-day and 90-day mortality in low and lower middle income countries, and only with early mortality in high-income countries. Multivariate analysis showed that qSOFA remained associated with 28-day mortality even after adjustments for confounders. The study also compared the predictive performance of qSOFA with APACHE II, SIRS, and SOFA, and explored the impact of lactate measurement on qSOFA sepsis mortality prediction. Additionally, the study described the characteristics and outcomes of different clinical sepsis phenotypes in patients meeting Sepsis-3 SOFA, SIRS, and qSOFA criteria. The findings suggest that qSOFA was independently associated with 28-day mortality in ICU patients admitted for sepsis, and its predictive performance varied across different income settings. The study also highlighted the clinical utility and limitations of qSOFA in prognosticating sepsis mortality, providing valuable insights for clinicians and researchers.

Advertisement

Reference -

Li, A., Ling, L., Qin, H. et al. Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings. Crit Care 28, 30 (2024). https://doi.org/10.1186/s13054-024-04804-7.




Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News